Clinical trial

Study of Islet Transplantation in Type 1 Diabetic Kidney Transplant Recipients

NCT00888628

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

BIOLOGICAL · Unmapped registry intervention Purified Pancreatic Islets Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Etanercept Normalized identity: etanerceptView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Study of Islet Transplantation in Type 1 Diabetic Kidney Transplant Recipients

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1, PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2009-05-01

PhasePHASE1 / PHASE2

Conditions

Diabetes Mellitus, Type Iunresolved

Interventions

Purified Pancreatic IsletsBIOLOGICAL

EtanerceptDRUG · verified · RxNorm: etanercept

Sponsors & collaborators

Massachusetts General Hospitallead sponsor

Boston Area Diabetes Endocrinology Research Center (funded by NIDDK)collaborator

Mapped research locations

BostonMassachusetts, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00888628 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.